Secondary Logo

Journal Logo

A review of psychological treatments for vomiting associated with paediatric functional gastrointestinal disorders

Jerson, Bradleya,b; Lamparyk, Katherinec; van Tilburg, Miranda A.L.d,e,f

doi: 10.1097/MOP.0000000000000800
GASTROENTEROLOGY AND NUTRITION: Edited by Bradley Barth
Free

Purpose of review Vomiting can be a primary symptom or associated with various other functional gastrointestinal disorders (FGIDs). The purpose of this review was to discuss the evidence for psychological treatments for vomiting in pediatric FGID.

Recent findings Vomiting of functional origin is an increasingly recognized symptom among children and adolescents. It is highly aversive and associated with disability and poor quality of life. Cognitive behavioral therapy, lifestyle modification (especially sleep), diaphragmatic breathing, and hypnosis can be helpful in preventing vomiting episodes and reducing disability. However, no randomized clinical trials have been performed. An evidence base for psychological treatments in children with vomiting of functional origin is highly needed.

Summary Increased evidence is demonstrating value and efficacy of incorporating psychogastroenterology practices into ongoing treatment plans for digestive conditions. Current psychological treatments are focused on prevention of vomiting through stress reduction and lifestyle modification, reduction of disability by limiting avoidance behaviours, as well as counteracting biological factors. However, psychological treatments have not been shown to be helpful during an acute vomiting episode. More research is needed to build an evidence base for psychological treatments in vomiting disorders.

aDivision of Digestive Diseases, Hepatology, & Nutrition and Division of Pediatric Psychology, Connecticut Children's Medical Center

bUniversity of Connecticut, School of Medicine, Hartford, Connecticut

cBehavioral GI Program, Cleveland Clinic Lerner College of Medicine of CWRU, Cleveland, Ohio

dCollege of Pharmacy & Health Sciences, Campbell University, Buies Creek

eDepartment of Medicine, University of North Carolina, Chapel Hill, North Carolina

fSchool of Social Work, University of Washington, Seattle, Washington, USA

Correspondence to Bradley Jerson, PhD, Division of Digestive Diseases, Hepatology, & Nutrition, Connecticut Children's Medical Center 282 Washington Avenue, Hartford, CT 06106, USA. Tel: +1 860 545 9560; fax: +1 860 545 9561; e-mail: bjerson@connecticutchildrens.org

Back to Top | Article Outline

INTRODUCTION

Vomiting is a primary symptom in many paediatric gastrointestinal conditions. It is technically defined as forceful oral expulsion of gastric contents associated with contraction of the abdominal and chest wall musculature. However, for individuals who present to both paediatric and gastrointestinal specialty offices, this term often becomes synonymous with many other behaviours, including ‘regurgitating’, ‘dry-heaving’, ‘ruminating’ and other behaviours that have both different phenotypes as well as underlying physiological mechanisms. Vomiting is often associated with functional gastrointestinal disorders (FGIDs). The purpose of this review is to discuss the evidence for psychological treatments of children with vomiting due to FGID. We will briefly discuss FGIDs associated with vomiting, the biopsychosocial model as a guiding principle to treatment and finally focus on cognitive behavioural therapy (CBT), hypnotherapy, diaphragmatic breathing and sleep hygiene for the treatment of vomiting.

Box 1

Box 1

Back to Top | Article Outline

VOMITING IN FUNCTIONAL GASTROINTESTINAL DISORDERS

FGIDs are considered common in children and adolescents and result in significant impairment and costs. FGIDs are diagnosed following Rome Criteria, currently in its fourth edition [1], and include specific diagnostic criteria for child and adolescent FGIDs that fall under three primary categories: functional nausea and vomiting disorders, functional abdominal pain disorders (FAPDs) and functional defecation disorders. Although vomiting is the predominant symptom in the first category, it is also prevalent in FAPDs, including abdominal migraine. The diagnostic criteria are based on the biopsychosocial model and require clinical history and physical examination. Specific diagnostic criteria are summarized in Table 1.

Table 1

Table 1

Cyclic vomiting syndrome (CVS) is characterized by stereotypical and repeated episodes of intense and repeated vomiting with a return to baseline health between episodes [1]. Prevalence rates have varied from 0.2 to 6.2% in population-based samples [2], and with updated diagnostic criteria from Rome IV as 2% in children above 4 years old [3▪], although it is believed that the disorder is largely under-recognized and frequently misdiagnosed [4▪▪]. CVS is associated with lower health-related quality of life in the affected child as compared to both healthy controls as well other gastrointestinal disorders [5] and has more recently been associated with poor family health-related quality of life as well [6]. A case of warning that CVS can be due to cannabinoid hyperemesis syndrome (CHS) [7], increasingly recognized in areas that have legalized recreational cannabis use [8,9]. CHS will not be a focus of this review.

Functional vomiting is newly described in the Rome IV [1] criteria and affects only a small number of children and adolescents (1.4% in a US population, 3). The Rome IV committee adopted criteria previously described in the adult population based on clinical experience, particularly in children with co-occurring anxiety and depression [1].

Rumination syndrome is characterized by the repeated regurgitation of recently ingested gastric contents and has been likened to a tic or an exaggerated belch reflex [1]. Regurgitated food can be swallowed or spit out. The latter is not considered vomiting, by the definition given above, although some patients and their families may call it such. For this reason, we will include rumination in this review. Prevalence of rumination syndrome has ranged from 0 to 5.3% in population-based studies [2,3▪], although these rates may be minimized due to decreased accuracy of parent report of youth symptoms. Rumination syndrome has been associated with significant impairment with one study finding 73% of children having missed school or work due to symptoms and 46% requiring hospitalization for the evaluation or treatment of symptoms [10].

Vomiting can also be associated with FAPDs. Nausea is reported in almost half of all children and adolescents with FAPDs [11]. A recent prospective study of adolescents with FAPD identified that vomiting was present in 27% of patients who reported comorbid nausea, compared with only 3% of individuals with FAPD without nausea [3▪,12▪▪]. Abdominal migraine, in particular, is often associated with nausea and vomiting, but this is a fairly uncommon condition affecting only a small number of all functional abdominal pain patients [3▪]. The presence of nausea in children with functional abdominal pain is associated with worse health outcomes in young adulthood and a higher extraintestinal symptom burden, worse quality of life and impaired functioning [11,12▪▪], which is notable in that nausea and vomiting are frequently comorbid.

Avoidant restrictive food intake disorder (ARFID) is a new diagnosis included in the DSM-5. ARFID is characterized by fear of consuming food secondary to postprandial nausea or discomfort, and subsequent severe food intake restriction. In addition to compromising their nutrition, the increased restriction will likely inadvertently worsen nausea and other digestive sensitivities. A recent retrospective chart review of adolescents and young adults admitted to an intensive treatment programme found that a majority of patients with ARFID were vomiting regularly at admission, and most stopped during treatment and responded to behavioural interventions such as psychoeducation and relaxation training [13]. ARFID is distinct from other diagnoses of disordered eating (e.g. anorexia nervosa) in that body image concerns are not typically reported. In a recent study, 21% of adult patients with FGID also met criteria for ARFID [14].

Back to Top | Article Outline

BIOPSYCHOSOCIAL MODEL TO EXPLAIN VOMITING

Each of these conditions is best understood from a biopsychosocial conceptualization [15]. Briefly, early life factors including genetics, culture and the environment, shape the individual's psychological, social and physiological functioning. The central and enteral nervous system coordinate bidirectional interaction of these numerous psychosocial and physiological factors. This results in the FGID presentation as well as clinical and quality of life outcomes. Suggested mechanisms include bidirectional relationships between the stress response system and immune and inflammatory response systems and the gut microbiome and psychological symptoms [16▪▪,17].

Research has shown that functional vomiting disorders have biological, psychological and social underpinnings. For example, presenting symptoms for children with CVS may include a family history of migraine headaches [1], mitochondrial abnormalities and/or hypothalamic disturbances [18], and a high concurrent prevalence of anxiety disorders [5] and school difficulties. Similarly, rumination syndrome is also driven by biopsychosocial processes.

Rumination is primarily a behavioural disorder, in which there is a developed reflexive response during digestion of increased intragastric pressure by contraction of abdominal muscles and associated opening of the lower oesophageal sphincter. Rumination is typically the result of a triggering event, such as a previous infection (biological) boredom (social) or anxiety (psychological) or a combination of these factors [1,10]. As the current review focuses on psychological treatments, it is important to understand the role of both child and parent psychological factors in FGIDs. This literature is reviewed in detail elsewhere [19▪▪,20–22].

Compared with healthy children, patients with FGIDs as well as their parents have been found to have higher rates of psychological distress and somatization. Furthermore, psychological distress, somatization and coping (especially catastrophizing) are associated with more negative FGID outcomes such as increased symptoms and disability as well as decreased quality of life. Parents who model or reinforce illness behaviours rather than wellness behaviours also exacerbate symptoms and disability in their child. In CVS patients specifically, 47–82% suffer from anxiety [5,23] and the presence of anxiety predicts family health-related quality of life beyond physical symptom severity [6]. Although much of the research has focused on FGIDs more broadly, the results may be extrapolated to the specific symptom of vomiting given our broad understanding of the brain-gut axis.

Given that vomiting associated with FGIDs is best understood within a biopsychosocial framework, treatment should be multidisciplinary and may include psychological interventions. Little research is available supporting the efficacy of psychological interventions for these disorders. However, vomiting associated with FGIDs share common factors with FAPDs, and the benefits of psychological interventions is well established for these disorders [24,25]. Recent findings indicate that chronic nausea and vomiting demonstrate similar neural pathways to that of chronic pain conditions [26]. As such, psychological interventions that have been found to be efficacious for paediatric chronic pain may also be promising for associated symptoms of nausea and vomiting. In our experience, vomiting is an increasingly common factor for referral to a medical psychologist.

Back to Top | Article Outline

COGNITIVE BEHAVIOURAL THERAPY

Cognitive behavioural therapy is based on the premise that thoughts, feelings and behaviours all influence each other. In order to address this trifecta, CBT combines behavioural therapy (e.g. relaxation training) with cognitive therapy (e.g. psychoeducation, addressing catastrophizing). CBT is versatile, as the therapists can choose from a large tool box of techniques and individualize the treatment. This means CBT varies by patient, disorder and therapist. CBT is also time limited and focuses on tools to help manage one's (mental) health, which is an attractive treatment option for patients with medical disorders. The literature is robust for the benefits of CBT in treatment of FAPDs [27▪,28,29▪▪,30], although less is known about functional vomiting. Several case studies are available supporting the use CBT in CVS as well as rumination [31–33]. CBT interventions in FGID typically begin with symptom-specific psychoeducation of the brain-gut pathway. Additional cognitive interventions focus on identifying unhelpful/unrealistic thoughts and how to replace them with more adaptive thought. Behavioural interventions may include relaxation techniques, and teaching parents how to manage symptoms.

For patients with CVS, lifestyle modifications and stress management techniques (maintaining fluids, eating regularly without skipping meals, exercise, sleep hygiene, distress tolerance, awareness of triggers and so on) implemented during the interictal phase can reduce the likelihood of attacks and need for preventive medications. As vomiting is highly aversive, children and their families try to avoid activities that may increase the risk of vomiting. Limiting avoidance of symptoms inducing activities has been shown to help reduce symptoms of nausea in children with functional dyspepsia [34▪] and may be helpful for vomiting as well. Because parents often limit child activities over fear of vomiting, including parents in therapy is of utmost importance. This strategy is used in CBT treatment for individuals with emetophobia (a specific phobia of vomiting), with gradual exposure to feared stimuli and preventing use of compensatory anxiety-reducing responses.

CBT is also incorporated into treatment plans for ARFID, a psychiatric diagnosis that may develop in the context of an FGID and in which vomiting is a prevalent symptom. Thomas and Eddy [35] have created CBT-AR, a modified CBT protocol informed by best practices from CBT interventions for eating disorders as well as anxiety disorders (regular eating, psychoeducation about nutrition deficiencies, exposure and response prevention, behavioural experiments, relapse prevention). This intervention is still in the early stages of testing, but early data indicates feasibility, acceptability and efficacy [36].

One of the most frequent avoided activities is going to school. There are currently no data on the rates of school absenteeism for students whose primary complaints are nausea and vomiting; however, our clinical experiences reveal that it is common. School refusal is complex, and vomiting can predispose, precipitate and/or perpetuate school avoidance [37]. CBT has been effective in reducing school avoidance in general (not associated with medical symptoms specifically) [38,39]. When nausea and vomiting symptoms are more pronounced in the morning, as is often the case for youth with FGID, an entry-level intervention may be to delay the start time for students. However, if morning gastrointestinal symptoms are associated with other school-related stress (academic issues, peer difficulties and so on), then moving the morning start time will likely not address the underlying concerns. In addition, partnering with the school to identify unmet academic needs or other unrecognized burdens associated with missed exposure to content secondary to absenteeism is imperative.

Back to Top | Article Outline

DIAPHRAGMATIC BREATHING

Often considered the foundational tool of a paediatric coping skills toolbox within cognitive-behavioural therapy, diaphragmatic breathing is commonly recommended. Patients are instructed to inhale by contracting the diaphragm and expanding the abdomen [40]. This remains the gold standard treatment for most cases of rumination syndrome, as the technique appears to reduce postprandial intragastric pressure and increase esophagogastric junction zone pressure, balancing the gastroesophageal pressure gradient [41]. It should not be used as a first-line intervention for individuals with retching and vomiting unless obstruction, gastroparesis, central nervous system disorders and medication effects have been ruled out.

Back to Top | Article Outline

SLEEP HYGIENE

One of the most profound, and commonly replicated findings, is the significant role that sleep deprivation has on functional impairment experienced in youth with FGID [42,43]. Therefore, emphasizing sleep as a major therapeutic goal seems indicated. An interesting recent single-arm pilot study evaluated an innovative hybrid cognitive-behavioural therapy treatment addressing both sleep and pain outcomes in adolescents with migraine and insomnia [44]. Their protocol included three core treatment components from CBT-I (sleep hygiene education, stimulus control, sleep restriction) and four core components from CBT for pain management (psychoeducation, relaxation training, pleasant activity scheduling and positive thought tracking, and parent operant training for reinforcing adolescent skills practice and reduction of reinforcement of pain behaviours). About 70.5% of the youth showed at least a 50% reduction in headache frequency and significant improvements in sleep quality and hygiene. These data are encouraging for individuals who present with vomiting co-occurring within paediatric FGID based on the theorized similar pathways involved in each conditions, as well as a potential early intervention to reduce likelihood of vomiting episodes [4▪▪].

Back to Top | Article Outline

HYPNOTHERAPY

Gut-directed hypnotherapy targets visceral hypersensitivity, motility disturbances and hypervigilance to normative digestive sensations. This practice incorporates gut-focused imagery and hypnotic suggestions targeting the gastrointestinal tract [29▪▪,30]. Most paediatric studies have thus far only recognized hypnotherapy's highly effective value for paediatric irritable bowel syndrome and functional abdominal pain [28]. Recently published studies discuss the value in functional dyspepsia and also oesophageal disorders [45] in adults for individuals who have not responded to proton-pump inhibitor therapy. In our clinical experience, some patients with functional vomiting may benefit from hypnotherapy, but studies are needed to confirm these findings.

Back to Top | Article Outline

CONCLUSION

Chronic vomiting of functional origin is a highly aversive disorder that reduces children's quality of life and increases disability. Vomiting has psychosocial as well as biological underpinnings and multidisciplinary treatments are generally recommended. Unfortunately, most therapies have limited evidence base. Recent data have challenged the use of medications as entry-level interventions for various conditions (e.g. CHAMP study for paediatric migraine, [46]; abdominal pain predominant FGID [47]). Increased evidence is demonstrating value and efficacy of incorporating psychogastroenterology practices into ongoing treatment plans for digestive conditions [29▪▪,48▪]. Current psychological treatments are focused on prevention of vomiting through stress reduction and lifestyle modification, reduction of disability by limiting avoidance and safety-seeking behaviours, as well as counteracting biological factors (in the case of rumination). However, psychological treatments have not been developed to help during an acute vomiting episode. More research is needed to build an evidence base for psychological treatments in vomiting disorders.

Back to Top | Article Outline

Acknowledgements

None.

Back to Top | Article Outline

Financial support and sponsorship

None.

Back to Top | Article Outline

Conflicts of interest

Dr. van Tilburg is a consultant for Mahana Therapeutics. None of the products offered by Mahana Therapeutics are discussed in this manuscript.

Back to Top | Article Outline

REFERENCES AND RECOMMENDED READING

Papers of particular interest, published within the annual period of review, have been highlighted as:

  • ▪ of special interest
  • ▪▪ of outstanding interest
Back to Top | Article Outline

REFERENCES

1. Hyams JS, Di Lorenzo C, Saps M, et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology 2016; 150:1456–1468.
2. Boronat AC, Ferreira-Maia AP, Matijasevich A, Wang Y-P. Epidemiology of functional gastrointestinal disorders in children and adolescents: a systematic review. World J Gastroenterol 2017; 23:3915–3927.
3▪. Robin SG, Keller C, Zwiener R, et al. Prevalence of pediatric functional gastrointestinal disorders utilizing the Rome IV Criteria. J Pediatr 2018; 195:134–139.

An important update on prevalence rates on paediatric FGID using recently updated Rome IV diagnostic criteria.

4▪▪. Kovacic K, Sood M, Venkatesan T. Cyclic vomiting syndrome in children and adults: what is new in 2018? Curr Gastroenterol Rep 2018; 20:46.

This update is an important review of the relevant research and best practices research for diagnosis and comprehensive management of CVS.

5. Tarbell S, Li BUK. Psychiatric symptoms in children and adolescents with cyclic vomiting syndrome and their parents. Headache 2007; 48:259–266.
6. Wang-Hall J, Li BUK, Tarbell SE. Family health-related quality of life in pediatric cyclic vomiting syndrome. J Pediatr Gastroenterol Nutr 2018; 66:738–743.
7. Galli JA, Sawaya RA, Friedenberg FK. Cannabinoid hyperemesis syndrome. Curr Drug Abuse Rev 2011; 4:241–249.
8. Chen YC, Klig J. Cannabis-related emergencies in children and teens. Curr Opin Pediatr 2019; 31:291–296.
9. Monte AA, Shelton SK, Mills E, et al. Acute illness associated with cannabis use, by route of exposure: an observational study. Ann Intern Med 2019; [Epub ahead of print].
10. Chial HJ, Camilleri M, Williams DE, et al. Rumination syndrome in children and adolescents: diagnosis, treatment, and prognosis. Pediatrics 2003; 111:158–162.
11. Russell AC, Stone AL, Walker LS. Nausea in children with functional abdominal pain predicts poor health outcomes in young adulthood. Clin Gastroenterol Hepatol 2017; 15:706–711.
12▪▪. Kovacic K, Kapavarapu PK, Sood MR, et al. Nausea exacerbates symptom burden, quality of life, and functioning in adolescents with functional abdominal pain disorders. Neurogastroenterol Motil 2019; 31:e13595.

This is one of the first research studies to explore vomiting as a distinct symptom accompanying nausea in the context of paediatric FGID.

13. Makhzoumi SH, Schreyer CC, Hansen JL, et al. Hospital course of underweight youth with ARFID treated with a meal-based behavioral protocol in an inpatient-partial hospitalization program for eating disorders. Int J Eat Disord 2019; 52:428–434.
14. Zia JK, Riddle M, DeCou CR, et al. Prevalence of eating disorders, especially DSM-5's avoidant restrictive food intake disorder, in patients with functional gastrointestinal disorders: a cross-sectional online survey. Gastroenterology 2017; 152:S715–S716.
15. Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV. Gastroenterology 2016; 150:1262–1279. e2.
16▪▪. Reed-Knight B, Maddux MH, Deacy AD, et al. Brain–gut interactions and maintenance factors in pediatric gastroenterological disorders: recommendations for clinical care. Clin Pract Pediatr Psychol 2017; 5:93–105.

A well written and update primer on the brain-gut connection, application to all paediatric gastrointestinal conditions and description of tools for clinical practice.

17. van Tilburg MAL. Faure C, Thapar N, Di Lorenzo C. Integration of biomedical and psychosocial issues in pediatric functional gastrointestinal and motility disorders. Pediatric neurogastroenterology: gastrointestinal motility and functional disorders in children. Cham: Springer International Publishing; 2017. 71–80. https://doi.org/10.1007/978-3-319-43268-7_6
18. Donnet A, Redon S. Cyclic vomiting syndrome in children. Curr Pain Headache Rep 2018; 22:30.
19▪▪. Newton E, Schosheim A, Patel S, et al. The role of psychological factors in pediatric functional abdominal pain disorders. Neurogastroenterol Motil 2019. e13538.

An update to the psychological comorbidities and discovered mediating factors that have been implicated in paediatric FAPDs.

20. Taranukha T, Kumar VCS, Seamon A, et al. Depression, young age, chronic marijuana use, and interepisodic symptoms predict psychological distress in patients with cyclic vomiting syndrome. Neurogastroenterol Motil 2018; 30:e13245.
21. Hollier JM, van Tilburg MAL, Liu Y, et al. Multiple psychological factors predict abdominal pain severity in children with irritable bowel syndrome. Neurogastroenterol Motil 2019; 31:e13509.
22. Alioto A, Di Lorenzo C. Faure C, Thapar N, Di Lorenzo C. Rumination syndrome. Pediatric neurogastroenterology: gastrointestinal motility and functional disorders in children. Switzerland: Springer International Publishing; 2017. 437–444.
23. Tarbell SE, Millar A, Laudenslager M, et al. Anxiety and physiological responses to the Trier Social Stress Test for Children in adolescents with cyclic vomiting syndrome. Auton Neurosci 2017; 202:79–85.
24. Reed-Knight B, Claar RL, Schurman JV, et al. Implementing psychological therapies for functional GI disorders in children and adults. Expert Rev Gastroenterol Hepatol 2016; 10:981–984.
25. Abbott RA, Martin AE, Newlove-Delgado TV, et al. Psychosocial interventions for recurrent abdominal pain in childhood. Cochrane Database Syst Rev 2017; 1:CD010971.
26. Cangemi DJ, Kuo B. Practical perspectives in the treatment of nausea and vomiting. J Clin Gastroenterol 2019; 53:170–178.
27▪. Fisher E, Law E, Dudeney J, et al. Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst 2018; No. CD003968. DOI: 10.1002/14651858.CD003968.pub5.

A highly thorough review of the efficacy of certain therapies for paediatric chronic pain.

28. Rutten JM, Korterink JJ, Venmans LM, et al. Nonpharmacologic treatment of functional abdominal pain disorders: a systematic review. Pediatrics 2015; 135:522–535.
29▪▪. Keefer L, Palsson OS, Pandolfino JE. Best practice update: incorporating psychogastroenterology into management of digestive disorders. Gastroenterology 2018; 154:1249–1257.

An important study highlighting the updated data to support behavioural health integration to comprehensive management of gastrointestinal conditions.

30. Person H, Keefer L. Brain-gut therapies for pediatric functional gastrointestinal disorders and inflammatory bowel disease. Curr Gastroenterol Rep 2019; 21:12.
31. Slutsker B, Konichezky A, Gothelf D. Breaking the cycle: cognitive behavioral therapy and biofeedback training in a case of cyclic vomiting syndrome. Psychol Health Med 2010; 15:625–631.
32. Green AD, Alioto A, Mousa H, Di Lorenzo C. Severe pediatric rumination syndrome: successful interdisciplinary inpatient management. J Pediatr Gastroenterol Nutr 2011; 52:414–418.
33. Dalton WT, Czyzewski DI. Behavioral treatment of habitual rumination: case reports. Dig Dis Sci 2009; 54:1804–1807.
34▪. Bonnert M, Olén O, Lalouni M, et al. Internet-delivered exposure-based cognitive-behavioral therapy for adolescents with functional abdominal pain or functional dyspepsia: a feasibility study. Behav Ther 2019; 50:177–188.

This study demonstrates that internet-delivered EBT, with a mechanism of exposure and parental psychoeducation, is beneficial to youth with FAP and FD.

35. Cambridge University Press, Thomas JJ, Eddy KT. Cognitive-behavioral therapy for avoidant/restrictive food intake disorder: children, adolescents, and adults. 2018.
36. Thomas JJ, Becker KR, Wons O, et al. Cognitive-behavioral therapy for avoidant/restrict food intake disorder (CBT-AR): a pilot study demonstrating feasibility, efficacy, and acceptability. Presented at the Eating Disorder Research Society, Sydney, Australia; 2018.
37. Heyne D, Sauter FM, Ollendick TH, et al. Developmentally sensitive cognitive behavioral therapy for adolescent school refusal: rationale and case illustration. Clin Child Fam Psychol Rev 2014; 17:191–215.
38. Maynard BR, Heyne D, Brendel KE, et al. Treatment for school refusal among children and adolescents: a systematic review and meta-analysis. Res Soc Work Pract 2018; 28:56–67.
39. Hannan S, Davis E, Morrison S, et al. An open trial of intensive cognitive-behavioral therapy for school refusal. Evid Based Pract Child Adolesc Ment Health 2019; 0:1–13.
40. Chitkara DK, Van Tilburg M, Whitehead WE, Talley NJ. Teaching diaphragmatic breathing for rumination syndrome. Am J Gastroenterol 2006; 101:2449–2452.
41. Halland M, Pandolfino J, Barba E. Diagnosis and treatment of rumination syndrome. Clin Gastroenterol Hepatol 2018; 16:1549–1555.
42. Schurman JV, Friesen CA, Dai H, et al. Sleep problems and functional disability in children with functional gastrointestinal disorders: an examination of the potential mediating effects of physical and emotional symptoms. BMC Gastroenterol 2012; 12:142.
43. Christensen J, Noel M, Mychasiuk R. Neurobiological mechanisms underlying the sleep-pain relationship in adolescence: a review. Neurosci Biobehav Rev 2019; 96:401–413.
44. Law EF, Tham SW, Aaron RV, et al. Hybrid cognitive-behavioral therapy intervention for adolescents with co-occurring migraine and insomnia: a single-arm pilot trial. Headache 2018; 58:1060–1073.
45. Riehl ME, Chen JW. The proton pump inhibitor nonresponder: a behavioral approach to improvement and wellness. Curr Gastroenterol Rep 2018; 20:34.
46. Powers SW, Coffey CS, Chamberlin LA, et al. Trial of amitriptyline, topiramate, and placebo for pediatric migraine. N Engl J Med 2017; 376:115–124.
47. Bonilla S, Nurko S. Focus on the use of antidepressants to treat pediatric functional abdominal pain: current perspectives. Clin Exp Gastroenterol 2018; 11:365–372.
48▪. Beinvogl B, Burch E, Snyder J, et al. Multidisciplinary treatment reduces pain and increases function in children with functional gastrointestinal disorders. Clin Gastroenterol Hepatol 2019; 17:994–996.

A recent study demonstrating the value of a multidisciplinary approach, including psychology, in functional improvement in children with FGID.

Keywords:

cognitive-behavioural therapy; functional gastrointestinal disorders; nausea; psychogastroenterology; vomiting

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.